Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676724
Filing Date
2016-08-09
Accepted
2016-08-09 16:02:08
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d226999d10q.htm 10-Q 650857
2 EX-31.1 d226999dex311.htm EX-31.1 5897
3 EX-31.2 d226999dex312.htm EX-31.2 5922
4 EX-32.1 d226999dex321.htm EX-32.1 4246
11 GRAPHIC g226999txpg32.jpg GRAPHIC 127120
  Complete submission text file 0001193125-16-676724.txt   3414193

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20160630.xml EX-101.INS 378894
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20160630.xsd EX-101.SCH 35250
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20160630_cal.xml EX-101.CAL 37037
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20160630_def.xml EX-101.DEF 241213
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20160630_lab.xml EX-101.LAB 338879
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20160630_pre.xml EX-101.PRE 278395
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 161817801
SIC: 8093 Services-Specialty Outpatient Facilities, NEC